FDA on Tuesday announced the 14 members of a new Pharmacy Compounding Advisory Committee formed to advise the agency as it beefs up its compounding oversight, prompting quick concerns from the international compounding lobby that the panel lacks adequate representation of actual practicing pharmacists. Two groups that have pushed for stronger FDA compounding oversight -- Public Citizen and Pew Charitable Trusts -- have seats on the committee, which was called for by the Drug Quality and Security Act. The National...